	Cisplatin versus carboplatin as adjuvant chemotherapy for completely resected non-small cell lung cancer: a multicenter retrospective cohort study. Surg Today Hamaji M, Miyata R, Takeuchi J, Ozu N, Kohama T, Sumitomo R, Takahashi M, Fukada T, Kobayashi M, Kumaya Y, Chen-Yoshikawa TF. PMID: 42313168 [PubMed - as supplied by publisher]
	First-Line Alectinib Versus Ceritinib With or Without Brain Radiotherapy in ALK-Positive Non-Small Cell Lung Cancer with Brain Metastases: A Real-World Multicenter Study from Vietnam. Thorac Cancer Nguyen HG, Nguyen XH, Nguyen P, Nguyen TH, Vinh QB. PMID: 42313051 [PubMed - indexed for MEDLINE]
	Impact of local treatment on survival outcomes in patients with metastatic lung cancer with oligoprogression undergoing immunotherapy. Swiss Med Wkly Domenach B, Mismetti V, Bouleftour W, Bareille A, Tiffet O, Desage AL, Fournel P. PMID: 42312985 [PubMed - indexed for MEDLINE]
	Review Article \| Diagnosis and Early Detection of Lung Cancer: Present and Future Approaches. Gulf J Oncolog Fadelelmoula T. PMID: 42312823 [PubMed - indexed for MEDLINE]
	Unveiling the cognitive fog in lung cancer patients: non-invasive exploration of blood-brain barrier disruption and brain structural changes. Ann Med Zhang DF, Ma H, Zhang ZP, Ai J, Cao WT, Li ZH. PMID: 42312599 [PubMed - indexed for MEDLINE]
	RTsDEN: reverse task attention enabled deep learning model for lung cancer detection using computed tomography. Expert Rev Anticancer Ther Sundara Raj Retna Bai L, Joseph A, Sundara Raj Retna Bai F. PMID: 42312470 [PubMed - as supplied by publisher]
	Complete Response in Metastatic Rectal Cancer with Hepatic and Pulmonary Metastases Treated with Second-Line FOLFIRI plus Ramucirumab: A Case Report. Case Rep Oncol Hasegawa M, Okayama H, Kitabori Y, Yamauchi N, Nakajima T, Matsumoto S, Sato N, Saito M, Kono K. PMID: 42312106 [PubMed]
	A Phase II Trial of Perioperative Camrelizumab Plus Neoadjuvant Chemotherapy in Resectable Stage IIB-IIIB Lung Squamous Cell Carcinoma. MedComm (2020) Hu M, Liu S, Han Y, Wang F, Liu Y, Lu B, Li H, Gao Y, Wang Y, Yang W, Shi K, Xiao B, Wang Q, Du J, Lin H, Li X, Wang C, Zhang T. PMID: 42311860 [PubMed]
	Risk prediction models for postoperative atrial fibrillation in patients with lung cancer: a systematic review and meta-analysis. Front Cardiovasc Med Yang F, Sun T, Shang Y, Chen Y, Wu J, Shang X. PMID: 42311770 [PubMed]
	Current status and trends of immune-related adverse events in lung cancer treated with immune checkpoint inhibitors: a bibliometric analysis of the past decade (2016-2025). Front Immunol Guo B, Zhang G, Sang S, Ma X, Qi H. PMID: 42311664 [PubMed - indexed for MEDLINE]
	Predicting response to immunochemotherapy in EGFR-mutant lung adenocarcinoma after third-generation TKI resistance using CT radiomics-based habitat imaging. Front Immunol Qie S, Shi Y, Li J, Jia S, Yin X. PMID: 42311663 [PubMed - indexed for MEDLINE]
	Multimodal diagnostic network integrating infrared and mass spectra for lung cancer. Biomed Opt Express Huang L, Zhao X, Tian Y, Shao J, Liu G, Wu C. PMID: 42311313 [PubMed]
	Radiomics to understand pre-treatment tumor biology for resectable non-small cell lung cancer. Front Oncol Zollinger B, Pham D, Suzuki K. PMID: 42311254 [PubMed]
	Associations between systemic immune-inflammation index and immune-related hypothyroidism in non-small cell lung cancer patients receiving immune checkpoint inhibitors: a retrospective study. Front Oncol Dai W, Li Q, Wang M, Wang C, Cao H. PMID: 42311250 [PubMed]
	Evaluation of zongertinib for the treatment of metastatic non-squamous non-small cell lung cancer with HER2 TKD activating mutation. Expert Opin Pharmacother Chen M, Gandhib J, Wu S, Cheng H. PMID: 42311064 [PubMed - as supplied by publisher]
	Lung cancer multimodal auxiliary diagnosis based on entropy weight decision fusion. Biomed Eng Online Zhang H, Tang Y, Li P, Fan W, Chen X. PMID: 42310728 [PubMed - as supplied by publisher]
	Preoperative Predictors of Surgical Complexity After Neoadjuvant Immunochemotherapy in Non-small-cell Lung Cancer. Ann Surg Oncol Tane S, Nomura K, Watanabe T, Takamori S, Ohara S, Oiki H, Katsumata S, Takamori S, Nakatsuka M, Tenpaku H, Nakamura R, Notsuda H, Namba K, Minegishi K, Kitamura Y, Abe M, Takegahara K, Konno H, Mizuno K, Toyoda T, Muto S, Toda M, Endo M, Maniwa Y, Soh J, Ohde Y. PMID: 42310265 [PubMed - as supplied by publisher]
	Deep integration of clinical metadata with [(18)F]FDG PET/CT imaging for histological subtyping in non-small cell lung cancer: a multi-center study. Eur J Nucl Med Mol Imaging Zhang J, Zhang X, Wang J, Hao H, Hu D, Hu K, Li X, Li Y, Liu G, Tian R, Wu W, Ma X, Huang Y, Jin C, Zhong Y, Tian M, Zhang H. PMID: 42310216 [PubMed - as supplied by publisher]
	Repeatability of AI-quantified incidental findings on lung cancer screening CT scans in the NELSON trial. Eur Radiol Bunk S, Bruins Slot T, Bennink E, Sidorenkov G, van der Velden N, Schurink N, Lades F, Sebald M, Heuvelmans MA, Gietema HA, Aerts JG, de Bock GH, Schaefer-Prokop C, de Jong PA, Vliegenthart R, Mohamed Hoesein FAA, NELSON-POP consortium. PMID: 42310036 [PubMed - as supplied by publisher]
	Association Between Osimertinib Dose Reduction and Treatment Outcomes in First-Line EGFR-Mutated Advanced NSCLC: The Impact of Post-Progression Management. Thorac Cancer Oi I, Fujita K, Imakita T, Tukino M, Noguchi T, Okada Y, Yoshimura S, Fujimoto N, Toyama S, Watanabe A, Ito T, Kaku R, Kanai O, Ohuchi M, Tanizawa K, Sawai S, Mio T. PMID: 42309786 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 159616

Page 1 of 7981



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy